{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:35:00Z","timestamp":1791981300463,"version":"4.4.0"},"reference-count":218,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110072\/Z\/15\/Z"],"award-info":[{"award-number":["110072\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","award":["BB\/M011216\/1 & BB\/P012523\/1"],"award-info":[{"award-number":["BB\/M011216\/1 & BB\/P012523\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Fluoroquinolones (FQs) are arguably among the most successful antibiotics of recent times. They have enjoyed over 30 years of clinical usage and become essential tools in the armoury of clinical treatments. FQs target the bacterial enzymes DNA gyrase and DNA topoisomerase IV, where they stabilise a covalent enzyme-DNA complex in which the DNA is cleaved in both strands. This leads to cell death and turns out to be a very effective way of killing bacteria. However, resistance to FQs is increasingly problematic, and alternative compounds are urgently needed. Here, we review the mechanisms of action of FQs and discuss the potential pathways leading to cell death. We also discuss quinolone resistance and how quinolone treatment can lead to resistance to non-quinolone antibiotics.<\/jats:p>","DOI":"10.3390\/molecules25235662","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T20:06:09Z","timestamp":1606853169000},"page":"5662","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":406,"title":["Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-1261","authenticated-orcid":false,"given":"Natassja G.","family":"Bush","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-1776","authenticated-orcid":false,"given":"Isabel","family":"Diez-Santos","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Abbott","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-6430","authenticated-orcid":false,"given":"Anthony","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","article-title":"1,8-Naphthyridone derivatives. A new class of chemotherapeutic agents","volume":"91","author":"Lesher","year":"1962","journal-title":"J. Med. Pharm. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: An expanded \u201cDiscovery Story\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_3","first-page":"19","article-title":"The role of moxifloxacin in tuberculosis therapy","volume":"25","author":"Gillespie","year":"2016","journal-title":"ERR"},{"key":"ref_4","first-page":"455","article-title":"Quinolones: A comprehensive review","volume":"65","author":"Oliphant","year":"2002","journal-title":"Am. Fam. Physician"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_6","unstructured":"EMEA\/H\/A-31\/1452 (2018). Quinolone-and Fluoroquinolone-Containing Medicinal Products, European Commision."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.000475","article-title":"Mechanisms of quinolone action and resistance: Where do we stand?","volume":"66","author":"Correia","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: Decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","article-title":"The fluoroquinolone antibacterials: Past, present and future perspectives","volume":"16","author":"Appelbaum","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1086\/428051","article-title":"The quinolones: Past, present, and future","volume":"41","author":"Andriole","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bonev, B.B., and Brown, N.M. (2019). Fluoroquinolone Resistance. Bacterial Resistance to Antibiotics\u2014From Molecules to Man, John Wiley & Sons.","DOI":"10.1002\/9781119593522"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.jac.a020889","article-title":"Quinolone generations: Natural history or natural selection?","volume":"46","author":"Ball","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.10.1.20","article-title":"Bioevaluation of the antibacterial flumequine for urinary tract use","volume":"10","author":"Rohlfing","year":"1976","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.17.2.103","article-title":"In vitro antibacterial activity of AM-715, a new nalidixic acid analog","volume":"17","author":"Ito","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7326\/0003-4819-108-2-238","article-title":"Norfloxacin: A new targeted fluoroquinolone antimicrobial agent","volume":"108","author":"Wolfson","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/CMR.2.4.378","article-title":"Fluoroquinolone antimicrobial agents","volume":"2","author":"Wolfson","year":"1989","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: An update","volume":"11","author":"Michot","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/13.1.87","article-title":"The pharmacokinetics and tissue penetration of norfloxacin","volume":"13","author":"Adhami","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/AAC.27.1.76","article-title":"Activities of new quinoline derivatives against genital pathogens","volume":"27","author":"Aznar","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2165\/00003495-198530060-00003","article-title":"Norfloxacin","volume":"30","author":"Holmes","year":"1985","journal-title":"Drugs"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.29.4.639","article-title":"Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli","volume":"29","author":"Hooper","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.23.1.15","article-title":"Antibacterial activity of norfloxacin","volume":"23","author":"Norrby","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF01650504","article-title":"Worldwide clinical data on efficacy and safety of ciprofloxacin","volume":"16","author":"Schacht","year":"1988","journal-title":"Infection"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/515132","article-title":"Safety of long-term therapy with ciprofloxacin: Data analysis of controlled clinical trials and review","volume":"28","author":"Segev","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","unstructured":"World Health Organization (2017). WHO Model List of Essential Medicines, 20th List (March 2017, Amended August 2017), World Health Organization."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cr030101q","article-title":"Bacterial topoisomerase inhibitors:\u2009 Quinolone and pyridone antibacterial agents","volume":"105","author":"Mitscher","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ahuja, S.D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J.N., Becerra, M.C., Benedetti, A., Burgos, M., and Centis, R. (2012). Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9153 patients. PLoS Med., 9.","DOI":"10.1371\/annotation\/230240bc-bcf3-46b2-9b21-2e6e584f7333"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/313680","article-title":"Trovafloxacin-induced acute hepatitis","volume":"30","author":"Lucena","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","first-page":"54","article-title":"Safety of fluoroquinolones: An update","volume":"13","author":"Mandell","year":"2002","journal-title":"Can. J. Infect. Dis."},{"key":"ref_31","unstructured":"WHO (2017). Critically Important Antimicrobials for Human Medicine, World Health Organisation\u2014WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). [5th ed.]."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","article-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1073\/pnas.74.11.4772","article-title":"Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity","volume":"74","author":"Gellert","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1073\/pnas.74.11.4767","article-title":"Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme","volume":"74","author":"Sugino","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bush, N.G., Evans-Roberts, K., and Maxwell, A. (2015). DNA Topoisomerases. EcoSal Plus, 6.","DOI":"10.1128\/ecosalplus.esp-0010-2014"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bates, A.D., and Maxwell, A. (2005). DNA Topology, Oxford University Press. [2nd ed.].","DOI":"10.1093\/oso\/9780198567097.001.0001"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.73.11.3872","article-title":"DNA gyrase: An enzyme that introduces superhelical turns into DNA","volume":"73","author":"Gellert","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA Topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0959-440X(98)80006-7","article-title":"Type II DNA topoisomerases","volume":"8","author":"Berger","year":"1998","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/EC.00357-06","article-title":"Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: Unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit","volume":"6","author":"Dar","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.0400836101","article-title":"Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria","volume":"101","author":"Wall","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0092-8674(92)90558-T","article-title":"The capture of a DNA double helix by an ATP-dependent protein clamp: A key step in DNA transport by type II DNA topoisomerases","volume":"71","author":"Roca","year":"1992","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0033583598003424","article-title":"Moving one DNA double helix through another by a type II DNA topoisomerase: The story of a simple molecular machine","volume":"31","author":"Wang","year":"1998","journal-title":"Q. Rev. Biophys."},{"key":"ref_45","first-page":"377","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2958.1994.tb00458.x","article-title":"Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target of fluoroquinolones","volume":"13","author":"Ferrero","year":"1994","journal-title":"Mol. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1073\/pnas.92.25.11801","article-title":"Topoisomerase IV is a target of quinolones in Escherichia coli","volume":"92","author":"Khodursky","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ejmech.2013.01.057","article-title":"Antibacterial action of quinolones: From target to network","volume":"66","author":"Cheng","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/156802609789630947","article-title":"Quinolones: Action and resistance updated","volume":"9","author":"Drlica","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mustaev, A., Malik, M., Zhao, X., Kurepina, N., Luan, G., Oppegard, L.M., Hiasa, H., Marks, K.R., Kerns, R.J., and Berger, J.M. (2014). Fluoroquinolone-gyrase-DNA complexes: Two modes of drug binding. J. Biol. Chem.","DOI":"10.1074\/jbc.M113.529164"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nsmb.1604","article-title":"Structural insight into the quinolone\u2013DNA cleavage complex of type IIA topoisomerases","volume":"16","author":"Laponogov","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0167-4781(88)90153-4","article-title":"Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments","volume":"949","author":"Tornaletti","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/0006-2952(88)90493-5","article-title":"DNA unwinding induced by nalidixic acid binding to DNA","volume":"37","author":"Tornaletti","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/0006-2952(89)90505-4","article-title":"A reply: \u201cDo quinolones bind to DNA?\u201d\u2014Yes","volume":"38","author":"Shen","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1021\/bi500682e","article-title":"Role of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1093\/nar\/gkt124","article-title":"Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: Mechanistic basis of quinolone resistance","volume":"41","author":"Aldred","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: Quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0022-2836(79)90077-9","article-title":"DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid","volume":"131","author":"Snyder","year":"1979","journal-title":"J. Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.2000.4266","article-title":"The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex","volume":"304","author":"Wentzell","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/jmbi.1994.1586","article-title":"The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase","volume":"242","author":"Willmott","year":"1994","journal-title":"J. Mol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/jmbi.1996.0274","article-title":"DNA gyrase and topoisomerase IV on the bacterial chromosome: Quinolone-induced DNA cleavage","volume":"258","author":"Chen","year":"1996","journal-title":"J. Mol. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2958.2006.05275.x","article-title":"Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones","volume":"61","author":"Malik","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/27.3.319","article-title":"Biphasic kinetics of bacterial killing by quinolones","volume":"27","author":"Carret","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/AAC.01617-06","article-title":"Quinolone-mediated bacterial death","volume":"52","author":"Drlica","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jac\/dkz485","article-title":"Reactive oxygen species play a dominant role in all pathways of rapid quinolone-mediated killing","volume":"75","author":"Hong","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pgen.0020152","article-title":"Analysis of pleiotropic transcriptional profiles: A case study of DNA gyrase inhibition","volume":"2","author":"Jeong","year":"2006","journal-title":"PLoS Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1073\/pnas.111006998","article-title":"Topological challenges to DNA replication: Conformations at the fork","volume":"98","author":"Postow","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.embor.7400101","article-title":"A topological view of the replicon","volume":"5","author":"Schvartzman","year":"2004","journal-title":"EMBO Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12551-016-0240-8","article-title":"The dynamic interplay between DNA topoisomerases and DNA topology","volume":"8","author":"Seol","year":"2016","journal-title":"Biophys. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0092-8674(00)81740-7","article-title":"The structure of supercoiled intermediates in DNA replication","volume":"94","author":"Peter","year":"1998","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/jmbi.1998.2510","article-title":"Formation of knots in partially replicated DNA molecules","volume":"286","author":"Sogo","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"13725","DOI":"10.1074\/jbc.M115.642272","article-title":"Direct evidence for the formation of precatenanes during DNA replication","volume":"290","author":"Parra","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00018-010-0299-5","article-title":"In front of and behind the replication fork: Bacterial type IIA topoisomerases","volume":"67","author":"Sissi","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1365-2958.2005.04638.x","article-title":"Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo","volume":"56","author":"Pohlhaus","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/AAC.50.1.362-364.2006","article-title":"Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli","volume":"50","author":"Zhao","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Gutierrez, A., Stokes, J.M., and Matic, I. (2018). Our evolving understanding of the mechanism of quinolones. Antibiotics, 7.","DOI":"10.3390\/antibiotics7020032"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"48485","DOI":"10.1074\/jbc.M304217200","article-title":"The RuvAB branch migration complex can displace topoisomerase IV\u00b7quinolone\u00b7DNA ternary complexes","volume":"278","author":"Shea","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_82","first-page":"5077","article-title":"Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin","volume":"49","author":"Hsiang","year":"1989","journal-title":"Cancer Res."},{"key":"ref_83","first-page":"5908","article-title":"Interaction between replication forks and topoisomerase I-DNA cleavable complexes: Studies in a cell-free SV40 DNA replication system","volume":"53","author":"Tsao","year":"1993","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/MCB.20.11.3977-3987.2000","article-title":"Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5\u2019-phosphorylated DNA double-strand breaks by replication runoff","volume":"20","author":"Strumberg","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-7992(93)90097-F","article-title":"Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases","volume":"303","author":"Ortiz","year":"1993","journal-title":"Mutat. Res. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/AAC.32.8.1113","article-title":"Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12","volume":"32","author":"Chow","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1128\/AAC.34.12.2331","article-title":"Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli","volume":"34","author":"Piddock","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1128\/jb.91.2.768-773.1966","article-title":"Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality","volume":"91","author":"Deitz","year":"1966","journal-title":"J. Bacteriol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/AAC.00739-06","article-title":"Effect of anaerobic growth on quinolone lethality with Escherichia coli","volume":"51","author":"Malik","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"102837","DOI":"10.1016\/j.dnarep.2020.102837","article-title":"Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC)","volume":"89","author":"Sun","year":"2020","journal-title":"DNA Repair"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.dnarep.2014.03.020","article-title":"Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)","volume":"19","author":"Pommier","year":"2014","journal-title":"DNA Repair"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature08444","article-title":"A human 5\u2032-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage","volume":"461","author":"Zuma","year":"2009","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2443.2001.00452.x","article-title":"Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae","volume":"6","author":"Pouliot","year":"2001","journal-title":"Genes Cells"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1126\/science.286.5439.552","article-title":"Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes","volume":"286","author":"Pouliot","year":"1999","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1128\/AAC.00130-13","article-title":"SbcCD-mediated processing of covalent gyrase-DNA complex in Escherichia coli","volume":"57","author":"Aedo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1568-7864(03)00063-6","article-title":"Nucleolytic processing of a protein-bound DNA end by the E. coli SbcCD (MR) complex","volume":"2","author":"Connelly","year":"2003","journal-title":"DNA Repair"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Tamayo, M., Santiso, R., Gosalvez, J., Bou, G., and Fern\u00e1ndez, J.L. (2009). Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC Microbiol., 9.","DOI":"10.1186\/1471-2180-9-69"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3103\/S0891416818020039","article-title":"Molecular and genetic characteristics of cell death in prokaryotes","volume":"33","author":"Andryukov","year":"2018","journal-title":"Mol. Gen. Microbiol. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2016.12.008","article-title":"The role of reactive oxygen species in antibiotic-mediated killing of bacteria","volume":"25","author":"Coenye","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2741\/4555","article-title":"Base excision repair of oxidative DNA damage: From mechanism to disease","volume":"22","author":"Whitaker","year":"2017","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.micro.57.030502.090938","article-title":"Pathways of oxidative damage","volume":"57","author":"Imlay","year":"2003","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-pharmtox-010814-124712","article-title":"Unraveling the physiological complexities of antibiotic lethality","volume":"55","author":"Dwyer","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1073\/pnas.1901730116","article-title":"Post-stress bacterial cell death mediated by reactive oxygen species","volume":"116","author":"Hong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/msb4100135","article-title":"Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli","volume":"3","author":"Dwyer","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.1232751","article-title":"Cell death from antibiotics without the involvement of reactive oxygen species","volume":"339","author":"Liu","year":"2013","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.1232688","article-title":"Killing by bactericidal antibiotics does not depend on reactive oxygen species","volume":"339","author":"Keren","year":"2013","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1126\/science.1219192","article-title":"Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics","volume":"336","author":"Foti","year":"2012","journal-title":"Science"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.celrep.2015.09.059","article-title":"Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage","volume":"13","author":"Belenky","year":"2015","journal-title":"Cell Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrmicro3032","article-title":"The molecular mechanisms and physiological consequences of oxidative stress: Lessons from a model bacterium","volume":"11","author":"Imlay","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mib.2015.01.004","article-title":"Diagnosing oxidative stress in bacteria: Not as easy as you might think","volume":"24","author":"Imlay","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41564-017-0037-y","article-title":"Contribution of reactive oxygen species to thymineless death in Escherichia coli","volume":"2","author":"Hong","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"D\u00f6rr, T., Lewis, K., and Vuli\u0107, M. (2009). SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000760"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Henderson, M.L., and Kreuzer, K.N. (2015). Functions that protect Escherichia coli from tightly bound DNA-protein complexes created by mutant EcoRII methyltransferase. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128092"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/jb.134.3.1195-1198.1978","article-title":"Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid","volume":"134","author":"McDaniel","year":"1978","journal-title":"J. Bacteriol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"a012674","DOI":"10.1101\/cshperspect.a012674","article-title":"DNA damage responses in prokaryotes: Regulating gene expression, modulating growth patterns, and manipulating replication forks","volume":"5","author":"Kreuzer","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.molcel.2019.02.037","article-title":"Gamblers: An antibiotic-induced evolvable cell subpopulation differentiated by reactive-oxygen-induced general stress response","volume":"74","author":"Pribis","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1128\/JB.00358-10","article-title":"RpoS, the stress response sigma factor, plays a dual role in the regulation of Escherichia coli\u2019s error-prone DNA polymerase IV","volume":"192","author":"Storvik","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_120","first-page":"25","article-title":"Antibiotics and bacterial resistance in the 21st century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/jac\/dkg483","article-title":"Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data","volume":"53","author":"Phillips","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/jac\/dkt212","article-title":"Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: Links to prescribing change?","volume":"68","author":"Livermore","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/infdis\/jiv279","article-title":"The rise of fluoroquinolone-resistant Escherichia coli in the community: Scarier than we thought","volume":"212","author":"Spellberg","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1155\/2012\/976273","article-title":"Global fluoroquinolone resistance epidemiology and implictions for clinical use","volume":"2012","author":"Dalhoff","year":"2012","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3947\/ic.2014.46.4.226","article-title":"Clinical importance and epidemiology of quinolone resistance","volume":"46","author":"Kim","year":"2014","journal-title":"Infect. Chemother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/AAC.34.6.1271","article-title":"Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli","volume":"34","author":"Yoshida","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Avalos, E., Catanzaro, D., Catanzaro, A., Ganiats, T., Brodine, S., Alcaraz, J., and Rodwell, T. (2015). Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: A systematic review. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120470"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1574-6968.1995.tb07810.x","article-title":"A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella Typhimurium","volume":"132","author":"Gensberg","year":"1995","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.35.8.1647","article-title":"Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli","volume":"35","author":"Yoshida","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/42294","article-title":"Crystal structure of the breakage-reunion domain of DNA gyrase","volume":"388","author":"Jackson","year":"1997","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.45.8.2378-2380.2001","article-title":"Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-retermining region","volume":"45","author":"Friedman","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/JB.185.23.6883-6892.2003","article-title":"Quinolone resistance due to reduced target enzyme expression","volume":"185","author":"Ince","year":"2003","journal-title":"J. Bacteriol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jac\/18.6.667","article-title":"Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives","volume":"18","author":"Uccelli","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jac\/18.5.575","article-title":"Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations","volume":"18","author":"Weisser","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/AAC.31.4.531","article-title":"Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones","volume":"31","author":"Weisser","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Pascual","year":"1998","journal-title":"Lancet"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bi052130w","article-title":"Pentapeptide repeat proteins","volume":"45","author":"Vetting","year":"2006","journal-title":"Biochem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/AAC.47.2.559-562.2003","article-title":"Prevalence of plasmid-mediated quinolone resistance","volume":"47","author":"Jacoby","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1128\/AAC.45.12.3387-3392.2001","article-title":"Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA","volume":"45","author":"Montero","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1016\/j.jmb.2019.05.050","article-title":"The microbial toxin microcin B17: Prospects for the development of new antibacterial agents","volume":"431","author":"Collin","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1110699","article-title":"A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA","volume":"308","author":"Hegde","year":"2005","journal-title":"Science"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1093\/nar\/gkq1296","article-title":"Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: Conserved surface loops direct the activity of a Qnr protein from a gram-negative bacterium","volume":"39","author":"Xiong","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/j.1460-2075.1988.tb03018.x","article-title":"The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell","volume":"7","author":"Garrido","year":"1988","journal-title":"EMBO J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/AAC.01292-15","article-title":"Protective effect of Qnr on agents other than quinolones that target DNA gyrase","volume":"59","author":"Jacoby","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: A new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/AAC.38.6.1284","article-title":"Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro","volume":"38","author":"Heisig","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","article-title":"Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals","volume":"40","author":"Everett","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.febslet.2011.04.054","article-title":"Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria","volume":"585","author":"Bolla","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance","volume":"25","author":"Hancock","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.41.10.2067","article-title":"Regulation of chromosomally mediated multiple antibiotic resistance: The mar regulon","volume":"41","author":"Alekshun","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular Mechanisms of Antibacterial Multidrug Resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/138945008785747824","article-title":"Membrane permeability and regulation of drug \u201cinflux and efflux\u201d in enterobacterial pathogens","volume":"9","author":"Bolla","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0006-2952(00)00291-4","article-title":"Antibiotic efflux pumps","volume":"60","author":"Balzi","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/s41467-020-17735-y","article-title":"Efflux pump activity potentiates the evolution of antibiotic resistance across Staphylococcus aureus isolates","volume":"11","author":"Papkou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: Efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","author":"Schmalstieg","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_156","first-page":"22","article-title":"Quinolone resistance: Much more than predicted","volume":"2","year":"2011","journal-title":"Front. Microbiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/28.2.185","article-title":"Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiplyresistant (marA) type strains","volume":"28","author":"Piddock","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: A multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874285801307010059","article-title":"Multidrug efflux pumps in Staphylococcus aureus: An update","volume":"7","author":"Costa","year":"2013","journal-title":"Open Microbiol J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/AAC.40.5.1266","article-title":"Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones","volume":"40","author":"Goldman","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1128\/AAC.44.4.814-820.2000","article-title":"Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli","volume":"44","author":"Kern","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.40.7.1695","article-title":"Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli","volume":"40","author":"Maneewannakul","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/AAC.42.8.2089","article-title":"Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli","volume":"42","author":"Oethinger","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_164","first-page":"195","article-title":"Resistance to non-quinolone antimicrobials in commensal Escherichia coli isolates from chickens treated orally with enrofloxacin","volume":"63","author":"Jurado","year":"2015","journal-title":"Jpn. J. Vet. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2010.01.003","article-title":"Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis","volume":"37","author":"Kohanski","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3168\/jds.2014-8521","article-title":"Effect of on-farm use of antimicrobial drugs on resistance in fecal Escherichia coli of preweaned dairy calves","volume":"97","author":"Pereira","year":"2014","journal-title":"J. Dairy Sci."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Chuppava, B., Keller, B., El-Wahab, A.A., Mei\u00dfner, J., Kietzmann, M., and Visscher, C. (2018). Resistance of Escherichia coli in turkeys after therapeutic or environmental exposition with enrofloxacin depending on flooring. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15091993"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e01824-18","DOI":"10.1128\/AAC.01824-18","article-title":"Resistance and virulence mechanisms of Escherichia coli selected by Enrofloxacin in Chicken","volume":"63","author":"Li","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.resmic.2009.03.003","article-title":"Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response","volume":"160","author":"Tattevin","year":"2009","journal-title":"Res. Microbiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1128\/AAC.00358-09","article-title":"Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli","volume":"53","author":"Lopez","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2958.2007.05642.x","article-title":"Antibiotic-mediated recombination: Ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli","volume":"64","author":"Lopez","year":"2007","journal-title":"Mol. Microbiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/JB.01464-06","article-title":"Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin","volume":"189","author":"Cirz","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1128\/JB.00807-06","article-title":"Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin","volume":"188","author":"Cirz","year":"2006","journal-title":"J. Bacteriol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/jac\/dki191","article-title":"Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates","volume":"56","author":"Gillespie","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jac\/dkn387","article-title":"Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin","volume":"62","author":"Hinds","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/CMR.00002-11","article-title":"Food animals and antimicrobials: Impacts on human health","volume":"24","author":"Marshall","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vetmic.2017.05.026","article-title":"The phenotypic and molecular resistance induced by a single-exposure to sub-mutant prevention concentration of marbofloxacin in Salmonella Typhimurium isolates from swine","volume":"207","author":"Lee","year":"2017","journal-title":"Vet. Microbiol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/00365549609037954","article-title":"Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin","volume":"28","author":"Pers","year":"1996","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1600-0463.2006.apm_357.x","article-title":"Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp","volume":"114","author":"Cebrian","year":"2006","journal-title":"APMIS"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1038\/s41598-020-65602-z","article-title":"Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli","volume":"10","author":"Ching","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1574-6968.1987.tb02213.x","article-title":"Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents","volume":"41","author":"Piddock","year":"1987","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/00222615-29-2-139","article-title":"4-Quinolones and the SOS response","volume":"29","author":"Lewin","year":"1989","journal-title":"J. Med. Microbiol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/mutage\/5.1.63","article-title":"Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones","volume":"5","author":"Ysern","year":"1990","journal-title":"Mutagenesis"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Cirz, R.T., Chin, J.K., Andes, D.R., de Crecy-Lagard, V., Craig, W.A., and Romesberg, F.E. (2005). Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol., 3.","DOI":"10.1371\/journal.pbio.0030176"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.50.1.220-225.2006","article-title":"Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria","volume":"50","author":"Cirz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jac\/dkq496","article-title":"Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials","volume":"66","author":"Thi","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev-micro-090817-062139","article-title":"Antibiotic-induced genetic variation: How it arises and how it can be prevented","volume":"72","author":"Blazquez","year":"2018","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1128\/AAC.01415-16","article-title":"Mutational consequences of ciprofloxacin in Escherichia coli","volume":"60","author":"Song","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"E2498","DOI":"10.1073\/pnas.1601208113","article-title":"Antibiotic treatment enhances the genome-wide mutation rate of target cells","volume":"113","author":"Long","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijantimicag.2015.04.008","article-title":"Fluoroquinolone induction of phage-mediated gene transfer in multidrug-resistant Salmonella","volume":"46","author":"Bearson","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41467-019-09058-4","article-title":"Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic","volume":"10","author":"Barrett","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/AAC.02552-13","article-title":"Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens","volume":"58","author":"Goneau","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1534\/genetics.113.152306","article-title":"Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway","volume":"195","author":"Theodore","year":"2013","journal-title":"Genetics"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.molcel.2017.11.012","article-title":"Understanding and sensitizing density-dependent persistence to quinolone antibiotics","volume":"68","author":"Gutierrez","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","article-title":"Persistent bacterial infections and persister cells","volume":"15","author":"Fisher","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"20150885","DOI":"10.1098\/rspb.2015.0885","article-title":"The SOS response increases bacterial fitness, but not evolvability, under a sublethal dose of antibiotic","volume":"282","author":"Kojadinovic","year":"2015","journal-title":"Proc. R. Soc. B"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s41669-016-0007-y","article-title":"Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years\u2019 Experience 1991\u20132015","volume":"1","author":"Almalki","year":"2017","journal-title":"Pharmacoecon. Open"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Durkin, M.J., Keller, M., Butler, A.M., Kwon, J.H., Dubberke, E.R., Miller, A.C., Polgreen, P.M., and Olsen, M.A. (2018). An assessment of inappropriate antibiotic use and guideline adherence for uncomplicated urinary tract infections. Open Forum Infect. Dis., 5.","DOI":"10.1093\/ofid\/ofy198"},{"key":"ref_199","first-page":"378","article-title":"Rational use of the fluoroquinolones","volume":"109","author":"Richards","year":"2019","journal-title":"S. Afr. Med. J. S. Afr. Med. Tydskr."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e030747","DOI":"10.1136\/bmjopen-2019-030747","article-title":"Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: A systematic literature review protocol","volume":"9","author":"Ching","year":"2019","journal-title":"BMJ Open"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40121-018-0198-x","article-title":"Delafloxacin: Place in therapy and review of microbiologic, clinical and pharmacologic properties","volume":"7","author":"Jorgensen","year":"2018","journal-title":"Infect. Dis. Ther"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Gualerzi, C.O., Brandi, L., Fabbretti, A., and Pon, C.L. (2014). Recent developments in inhibitors of bacterial type IIA topoisomerases. Antibiotics: Targets, Mechanisms and Resistance, Wiley-VCH Verlag GmbH & Co.","DOI":"10.1002\/9783527659685"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2147\/DDDT.S106071","article-title":"Delafloxacin: Design, development and potential place in therapy","volume":"11","author":"Candel","year":"2017","journal-title":"Drug Design Dev. Ther."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1128\/AAC.46.8.2712-2715.2002","article-title":"Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniae","volume":"46","author":"Houssaye","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/AAC.46.2.522-524.2002","article-title":"Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/AAC.45.12.3544-3547.2001","article-title":"Target preference of 15 duinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition","volume":"45","author":"Takei","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/AAC.43.2.302","article-title":"ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae","volume":"43","author":"Varon","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/AAC.47.1.77-81.2003","article-title":"Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae","volume":"47","author":"Kishii","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"E4492","DOI":"10.1073\/pnas.1700721114","article-title":"Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase","volume":"114","author":"Chan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/cb500629k","article-title":"Bypassing fluoroquinolone resistance with quinazolinediones: Studies of drug\u2013gyrase\u2013DNA complexes having implications for drug design","volume":"9","author":"Drlica","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1093\/nar\/gky181","article-title":"A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance","volume":"46","author":"Germe","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1021\/acs.jmedchem.7b01892","article-title":"Imidazopyrazinones (IPYs): Non-quinolone bacterial topoisomerase inhibitors showing partial cross-resistance with quinolones","volume":"61","author":"Jeannot","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Askoura, M., Mottawea, W., Abujamel, T., and Taher, I. (2011). Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa. Libyan J. Med., 6.","DOI":"10.3402\/ljm.v6i0.5870"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e00163-16","DOI":"10.1128\/mSphere.00163-16","article-title":"Systematically altering bacterial SOS activity under stress reveals therapeutic strategies for potentiating antibiotics","volume":"1","author":"Mo","year":"2016","journal-title":"mSphere"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fmicb.2018.01438","article-title":"DNA damage repair and drug efflux as potential targets for reversing low or intermediate ciprofloxacin resistance in E. coli K-12","volume":"9","author":"Klitgaard","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"e00971-17","DOI":"10.1128\/mBio.00971-17","article-title":"Quinolone resistance reversion by targeting the SOS response","volume":"8","author":"Recacha","year":"2017","journal-title":"mBio"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/jac\/dkz210","article-title":"N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli","volume":"74","author":"Valencia","year":"2019","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5662\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:40:04Z","timestamp":1760179204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":218,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["molecules25235662"],"URL":"https:\/\/doi.org\/10.3390\/molecules25235662","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}